Arcutis Biotherapeutics Inc

ARQTNASDAQ · US

Holders

REDUCEDT+30
Matsuda Masaru
Arcutis Biotherapeutics Inc · NASDAQ
−3,674 sh · $91.9K
Filed 18 Sept 2026SEC Form 4view source
ACQUIREDT+30
Welgus Howard G.
Arcutis Biotherapeutics Inc · NASDAQ
+1,019 sh · $7.7K
Filed 17 Sept 2026SEC Form 4view source
ACQUIREDT+30
Welgus Howard G.
Arcutis Biotherapeutics Inc · NASDAQ
+2,255 sh · $19.5K
Filed 17 Sept 2026SEC Form 4view source
ACQUIREDT+30
Welgus Howard G.
Arcutis Biotherapeutics Inc · NASDAQ
+822 sh · $5.4K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDT+30
Welgus Howard G.
Arcutis Biotherapeutics Inc · NASDAQ
−4,730 sh · $114.4K
Filed 17 Sept 2026SEC Form 4view source
REDUCEDStale
Matsuda Masaru
Arcutis Biotherapeutics Inc · NASDAQ
−9,989 sh · $250.0K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Curran Terrie
Arcutis Biotherapeutics Inc · NASDAQ
−11,148 sh · $279.0K
Filed 28 Aug 2026SEC Form 4view source
ACQUIREDStale
Curran Terrie
Arcutis Biotherapeutics Inc · NASDAQ
+27,052 sh · $233.5K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Curran Terrie
Arcutis Biotherapeutics Inc · NASDAQ
−27,052 sh · $677.1K
Filed 28 Aug 2026SEC Form 4view source
ACQUIREDStale
Curran Terrie
Arcutis Biotherapeutics Inc · NASDAQ
+11,148 sh · $83.7K
Filed 28 Aug 2026SEC Form 4view source